Cargando…
Pharmacotherapy of Insomnia with Ramelteon: Safety, Efficacy and Clinical Applications
Ramelteon is a tricyclic synthetic analog of melatonin that acts specifically on MT(1) and MT(2) melatonin receptors. Ramelteon is the first melatonin receptor agonist approved by the Food and Drug Administration (FDA) for the treatment of insomnia characterized by sleep onset difficulties. Ramelteo...
Autores principales: | Pandi-Perumal, Seithikurippu R., Spence, D. Warren, Verster, Joris C., Srinivasan, Venkatramanujam, Brown, Gregory M., Cardinali, Daniel P., Hardeland, Rüdiger |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663615/ https://www.ncbi.nlm.nih.gov/pubmed/23861638 http://dx.doi.org/10.4137/JCNSD.S1611 |
Ejemplares similares
-
Melatonin and Its Agonist Ramelteon in Alzheimer's Disease: Possible Therapeutic Value
por: Srinivasan, Venkatramanujam, et al.
Publicado: (2010) -
Pharmacotherapy of Insomnia
por: Neubauer, David N, et al.
Publicado: (2018) -
Melatonin in Mitochondrial Dysfunction and Related Disorders
por: Srinivasan, Venkatramanujam, et al.
Publicado: (2011) -
Critical appraisal of ramelteon in the treatment of insomnia
por: Mets, Monique AJ, et al.
Publicado: (2010) -
Possible Application of Melatonin in Long COVID
por: Cardinali, Daniel P., et al.
Publicado: (2022)